<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01212705</url>
  </required_header>
  <id_info>
    <org_study_id>BW2126/10</org_study_id>
    <nct_id>NCT01212705</nct_id>
  </id_info>
  <brief_title>Effect of Adaptive Servoventilation on Cardiac Function in Chronic Heart Failure and Cheyne-Stokes Respiration</brief_title>
  <official_title>Effect of Adaptive Servoventilation on Cardiac Function, Exercise Tolerance and Quality of Life in Patients With Chronic Heart Failure and Cheyne-Stokes Respiration</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Military Institute of Medicine, Poland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Military Institute of Medicine, Poland</source>
  <brief_summary>
    <textblock>
      Sleep disordered breathing is common in patients with chronic heart failure. Adaptive
      servoventilation is a novel method of treatment central sleep apnoea, especially associated
      with Cheyne-Stokes-respiration. The aim of the study is to investigate effect of adaptive
      servoventilation on cardiac function, exercise tolerance and quality of life in patients with
      chronic heart failure.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <number_of_arms>1</number_of_arms>
  <condition>Chronic Heart Failure</condition>
  <condition>Central Sleep Apnea</condition>
  <condition>Cheyne-Stokes Respiration</condition>
  <arm_group>
    <arm_group_label>ASV</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Adaptive servoventilation</intervention_name>
    <description>Background expiratory positive airway pressure with some inspiratory pressure support when needed</description>
    <arm_group_label>ASV</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  chronic heart failure with ejection fraction â‰¤45%

          -  optimal medical treatment for at least 1 month

          -  clinical diagnosis of Cheyne-Stokes respiration

        Exclusion Criteria:

          -  unstable heart failure

          -  stroke

          -  transient ischemic attack in last 6 months

          -  pacemaker, cardioverter-defibrillator or resynchronization device implanted less than
             6 months before study entrance

          -  severe chronic obstructive pulmonary disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Anna Kazimierczak</last_name>
    <role>Principal Investigator</role>
    <affiliation>Military Institute of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anna Kazimierczak</last_name>
    <phone>48 22 6818017</phone>
    <email>annakazimierczak@poczta.onet.pl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Krystian Krzyzanowski</last_name>
    <phone>48 512 356 207</phone>
    <email>krystian.krzyzanowski@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Military Institute of Medicine</name>
      <address>
        <city>Warsaw</city>
        <state>Szaserow 128</state>
        <zip>04-141</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>September 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 30, 2010</study_first_submitted>
  <study_first_submitted_qc>September 30, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 1, 2010</study_first_posted>
  <last_update_submitted>September 30, 2010</last_update_submitted>
  <last_update_submitted_qc>September 30, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 1, 2010</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Sleep Apnea, Central</mesh_term>
    <mesh_term>Cheyne-Stokes Respiration</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

